<?xml version="1.0" encoding="utf-8" standalone="yes"?><rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom"><channel><title>Notes on</title><link>https://quartz.jzhao.xyz/notes/</link><description>Recent content in Notes on</description><generator>Hugo -- gohugo.io</generator><language>en-us</language><atom:link href="https://quartz.jzhao.xyz/notes/index.xml" rel="self" type="application/rss+xml"/><item><title>Setup</title><link>https://quartz.jzhao.xyz/notes/setup/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://quartz.jzhao.xyz/notes/setup/</guid><description>Making your own Quartz Setting up Quartz requires a basic understanding of git. If you are unfamiliar, this resource is a great place to start!</description></item><item><title>Editing Content in Quartz</title><link>https://quartz.jzhao.xyz/notes/editing/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://quartz.jzhao.xyz/notes/editing/</guid><description>Editing Quartz runs on top of Hugo so all notes are written in Markdown.
Folder Structure Here&amp;rsquo;s a rough overview of what&amp;rsquo;s what.</description></item><item><title>Obsidian Vault Integration</title><link>https://quartz.jzhao.xyz/notes/obsidian/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://quartz.jzhao.xyz/notes/obsidian/</guid><description>Setup Obsidian is the preferred way to use Quartz. You can either create a new Obsidian Vault or link one that your already have.</description></item><item><title>Preview Changes</title><link>https://quartz.jzhao.xyz/notes/preview-changes/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://quartz.jzhao.xyz/notes/preview-changes/</guid><description>If you&amp;rsquo;d like to preview what your Quartz site looks like before deploying it to the internet, the following instructions guide you through installing the proper dependencies to run it locally.</description></item><item><title>Deploying Quartz to the Web</title><link>https://quartz.jzhao.xyz/notes/hosting/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://quartz.jzhao.xyz/notes/hosting/</guid><description>Hosting on GitHub Pages Quartz is designed to be effortless to deploy. If you forked and cloned Quartz directly from the repository, everything should already be good to go!</description></item><item><title/><link>https://quartz.jzhao.xyz/notes/1-Asthma-2022/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://quartz.jzhao.xyz/notes/1-Asthma-2022/</guid><description>Subject: Pharmacotherapy I Author: ‡∏û‡∏≠‡∏à‡∏≠ c91 rx80 Note: ‡πÇ‡∏õ‡∏£‡∏î‡∏≠‡πà‡∏≤‡∏ô‡∏ï‡∏≤‡∏°‡∏®‡∏£‡∏±‡∏ó‡∏ò‡∏≤ Finished Date: [[2023-02-01]]
Asthma and COVID-19 [!note] ‡πÇ‡∏Ñ‡∏ß‡∏¥‡∏î‡πÑ‡∏°‡πà‡πÑ‡∏î‡πâ‡∏ó‡∏≥‡πÉ‡∏´‡πâ‡πÄ‡∏™‡∏µ‡πà‡∏¢‡∏á Asthma ‡∏´‡∏£‡∏∑‡∏≠ Asthma ‡∏ó‡∏≥‡πÉ‡∏´‡πâ‡πÄ‡∏™‡∏µ‡πà‡∏¢‡∏á‡πÇ‡∏Ñ‡∏ß‡∏¥‡∏î ‡πÅ‡∏ï‡πà‡∏ñ‡πâ‡∏≤‡πÄ‡∏õ‡πá‡∏ô uncontrolled Asthma ‡∏à‡∏∞‡∏°‡∏µ‡∏≠‡∏±‡∏ï‡∏£‡∏≤‡∏Å‡∏≤‡∏£‡πÄ‡∏™‡∏µ‡∏¢‡∏ä‡∏µ‡∏ß‡∏¥‡∏ï‡∏ó‡∏µ‡πà‡∏™‡∏π‡∏á‡∏Ç‡∏∂‡πâ‡∏ô‡∏ñ‡πâ‡∏≤‡∏ï‡∏¥‡∏î‡πÇ‡∏Ñ‡∏ß‡∏¥‡∏î</description></item><item><title/><link>https://quartz.jzhao.xyz/notes/10-Drug-Induced-Ear-Disorder/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://quartz.jzhao.xyz/notes/10-Drug-Induced-Ear-Disorder/</guid><description>Middle Ear ‡∏ä‡∏±‡πâ‡∏ô‡∏Ç‡πâ‡∏≤‡∏á‡πÉ‡∏ô Ear-drum ‡πÄ‡∏õ‡πá‡∏ô‡∏ï‡πâ‡∏ô‡∏°‡∏≤ ‡∏°‡∏µ‡∏Å‡∏£‡∏∞‡∏î‡∏π‡∏Å M I S Inner Ear ‡∏°‡∏µ‡∏Ç‡∏≠‡∏á‡πÄ‡∏´‡∏•‡∏ß Lymphatic Fluid Semicircular canals: Gait &amp;amp; Balance ‡∏à‡∏∞‡∏°‡∏µ Hair Cell ‡∏ä‡∏∑‡πà‡∏≠ Maculae : static balance (Memo: maculae macuta (ta = static)) #recall1 !</description></item><item><title/><link>https://quartz.jzhao.xyz/notes/11-UGIB/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://quartz.jzhao.xyz/notes/11-UGIB/</guid><description>Upper GI ‡∏ï‡∏±‡∏î‡∏ó‡∏µ‡πà ligament of treitz ‡∏Ç‡∏∂‡πâ‡∏ô‡πÑ‡∏õ ‡∏ã‡∏∂‡πà‡∏á‡∏Å‡πá‡∏Ñ‡∏∑‡∏≠‡∏´‡∏•‡∏≠‡∏î‡∏≠‡∏≤‡∏´‡∏≤‡∏£‡∏à‡∏ô‡∏ñ‡∏∂‡∏á duodenum
Variceal bleeding is UGIB caused by esophageal or gastric varices.
‡πÉ‡∏ô‡∏™‡πÑ‡∏•‡∏î‡πå‡∏≠‡∏à.</description></item><item><title/><link>https://quartz.jzhao.xyz/notes/12-IBD/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://quartz.jzhao.xyz/notes/12-IBD/</guid><description>[!warning] IBD ‡πÑ‡∏°‡πà‡πÉ‡∏ä‡πà IBS IBS ‡πÄ‡∏õ‡πá‡∏ô functional ‡∏ï‡πà‡∏≤‡∏á‡∏ó‡∏µ‡πà IBD ‡∏ó‡∏µ‡πà‡∏û‡∏¢‡∏≤‡∏ò‡∏¥‡∏™‡∏†‡∏≤‡∏û‡∏ä‡∏±‡∏î‡πÄ‡∏à‡∏ô
Crohn&amp;rsquo;s Disease vs Ulcerative Colitis UC ‡∏à‡∏≥‡∏ß‡πà‡∏≤ &amp;ldquo;‡πÄ‡∏≠‡∏≤‡∏™‡∏¥&amp;rdquo; = S&amp;amp;S ‡πÄ‡∏î‡πà‡∏ô‡∏ï‡∏£‡∏á rectum ‡πÄ‡∏Ç‡πâ‡∏≤‡πÑ‡∏õ‡πÄ‡∏£‡∏∑‡πà‡∏≠‡∏¢ ‡πÜ ‡πÅ‡∏ï‡πà‡πÑ‡∏°‡πà‡∏•‡∏∂‡∏Å‡∏°‡∏≤‡∏Å ‡∏ï‡πà‡∏≤‡∏á‡∏à‡∏≤‡∏Å CD ‡∏ó‡∏µ‡πà‡∏Å‡∏£‡∏∞‡∏à‡∏±‡∏î‡∏Å‡∏£‡∏∞‡∏à‡∏≤‡∏¢ ‡πÄ‡∏û‡∏£‡∏≤‡∏∞ CD ‡∏Å‡∏£‡∏∞‡∏à‡∏≤‡∏¢‡∏Å‡∏£‡∏∞‡∏à‡∏≤‡∏¢ ‡∏î‡∏±‡∏á‡∏ô‡∏±‡πâ‡∏ô systemic symptoms ‡∏à‡∏∂‡∏á‡πÄ‡∏î‡πà‡∏ô‡∏Å‡∏ß‡πà‡∏≤‡∏°‡∏≤‡∏Å ‡πÜ ‡πÅ‡∏•‡∏∞‡∏¢‡∏±‡∏á‡∏°‡∏µ‡πÄ‡∏£‡∏∑‡πà‡∏≠‡∏á abdominal ‡∏ó‡∏µ‡πà‡πÄ‡∏î‡πà‡∏ô‡∏Å‡∏ß‡πà‡∏≤‡∏≠‡∏µ‡∏Å ‡πÄ‡∏ä‡πà‡∏ô tenderness, pain ‡∏Ø‡∏•‡∏Ø ‡∏£‡∏ß‡∏°‡∏ñ‡∏∂‡∏á‡πÑ‡∏Ç‡πâ‡∏≠‡∏µ‡∏Å‡∏î‡πâ‡∏ß‡∏¢ ‡πÅ‡∏•‡∏∞‡∏¢‡∏±‡∏á‡∏°‡∏µ aphthous or linear ulcers ‡∏≠‡∏µ‡∏Å UC ‡∏à‡∏∞‡∏Ñ‡πà‡∏≠‡∏ô‡∏Ç‡πâ‡∏≤‡∏á‡∏ä‡∏±‡∏î‡πÄ‡∏à‡∏ô (and common) ‡∏ß‡πà‡∏≤‡πÄ‡∏õ‡πá‡∏ô‡∏ó‡∏µ‡πà rectum ‡πÅ‡∏•‡∏∞‡∏Å‡∏≤‡∏£‡∏Å‡∏£‡∏∞‡∏à‡∏≤‡∏¢‡∏à‡∏∞‡πÄ‡∏õ‡πá‡∏ô‡πÅ‡∏ö‡∏ö continuous Epidemiology ‡∏û‡∏ö‡πÄ‡∏¢‡∏≠‡πÉ‡∏ô‡∏ï‡∏∞‡∏ß‡∏±‡∏ô‡∏ï‡∏Å UC ‡∏û‡∏ö‡πÑ‡∏î‡πâ‡∏ö‡πà‡∏≠‡∏¢‡∏Å‡∏ß‡πà‡∏≤ CD ‡πÅ‡∏ï‡πà‡∏ï‡πà‡∏≤‡∏á‡∏Å‡∏±‡∏ô‡∏ô‡∏¥‡∏î‡πÄ‡∏î‡∏µ‡∏¢‡∏ß Pathophysiology (‡∏´‡∏•‡∏≤‡∏Å‡∏´‡∏•‡∏≤‡∏¢, in short;) microbiome ‡πÄ‡∏™‡∏µ‡∏¢‡∏™‡∏°‡∏î‡∏∏‡∏• ‡∏Å‡∏≤‡∏£‡∏£‡∏±‡∏ö‡∏õ‡∏£‡∏∞‡∏ó‡∏≤‡∏ô‡∏≠‡∏≤‡∏´‡∏≤‡∏£ FODMAPs Psychological Stress TNF-a ‡∏ó‡∏µ‡πà‡∏™‡∏π‡∏á ‡∏ó‡∏≥‡πÉ‡∏´‡πâ th1 th2 dysfunction Severity Mild ‡∏ñ‡πà‡∏≤‡∏¢‡∏ô‡πâ‡∏≠‡∏¢‡∏Å‡∏ß‡πà‡∏≤‡∏ß‡∏±‡∏ô‡∏•‡∏∞ 4 ‡∏Ñ‡∏£‡∏±‡πâ‡∏á ESR ‡∏õ‡∏Å‡∏ï‡∏¥ (&amp;lt; 30 mm/h) Moderate ‡∏ñ‡πà‡∏≤‡∏¢‡∏°‡∏≤‡∏Å‡∏Å‡∏ß‡πà‡∏≤‡∏ß‡∏±‡∏ô‡∏•‡∏∞ 4 ‡∏Ñ‡∏£‡∏±‡πâ‡∏á systemic ‡πÄ‡∏•‡πá‡∏Å‡∏ô‡πâ‡∏≠‡∏¢ Severe ‡∏ñ‡πà‡∏≤‡∏¢‡πÄ‡∏õ‡πá‡∏ô‡πÄ‡∏•‡∏∑‡∏≠‡∏î ‡∏°‡∏≤‡∏Å‡∏Å‡∏ß‡πà‡∏≤ 6 ‡∏Ñ‡∏£‡∏±‡πâ‡∏á ‡∏°‡∏µ‡∏≠‡∏≤‡∏Å‡∏≤‡∏£‡πÄ‡∏ä‡∏¥‡∏á‡∏£‡∏∞‡∏ö‡∏ö Fulminant ‡∏ñ‡πà‡∏≤‡∏¢‡πÄ‡∏õ‡πá‡∏ô‡πÄ‡∏•‡∏∑‡∏≠‡∏î ‡∏°‡∏≤‡∏Å‡∏Å‡∏ß‡πà‡∏≤ 10 ‡∏Ñ‡∏£‡∏±‡πâ‡∏á ‡∏Å‡∏î‡πÄ‡∏à‡πá‡∏ö S&amp;amp;S of toxic megacolon Extraintestinal manifestations ‡πÄ‡∏î‡πà‡∏ô‡πÉ‡∏ô CD ‡πÄ‡∏ä‡πà‡∏ô Uveitis, Scleritis, Episcleritis ‡∏õ‡∏ß‡∏î‡∏Ç‡πâ‡∏≠ ‡∏õ‡∏ß‡∏î‡πÄ‡∏Ç‡πà‡∏≤‡∏Å‡πá‡∏û‡∏ö‡πÑ‡∏î‡πâ‡πÄ‡∏ä‡πà‡∏ô‡∏Å‡∏±‡∏ô Goal of Therapy: ‡∏•‡∏î‡∏Ñ‡∏ß‡∏≤‡∏°‡∏£‡∏∏‡∏ô‡πÅ‡∏£‡∏á ‡∏õ‡πâ‡∏≠‡∏á‡∏Å‡∏±‡∏ô‡∏Å‡∏≤‡∏£‡πÄ‡∏Å‡∏¥‡∏î‡∏†‡∏≤‡∏ß‡∏∞‡∏∞‡πÅ‡∏ó‡∏£‡∏Å‡∏ã‡πâ‡∏≠‡∏ô ‡∏•‡∏î‡∏Ñ‡∏ß‡∏≤‡∏°‡∏ñ‡∏µ‡πà‡πÉ‡∏ô‡∏Å‡∏≤‡∏£‡∏Å‡∏≥‡πÄ‡∏£‡∏¥‡∏ö ‡∏Å‡∏≤‡∏£‡∏£‡∏±‡∏Å‡∏©‡∏≤‡πÇ‡∏î‡∏¢‡∏Å‡∏≤‡∏£‡πÉ‡∏ä‡πâ‡∏¢‡∏≤ Salicylate derivatives ‡πÉ‡∏ä‡πâ‡πÑ‡∏î‡πâ‡∏ó‡∏±‡πâ‡∏á induction and maintenance ‡∏ï‡∏±‡∏ß active ‡∏Ñ‡∏∑‡∏≠ 5-aminosalicylic acid (mesalamine) ‡∏°‡∏µ‡∏ú‡∏•‡∏Ç‡πâ‡∏≤‡∏á‡πÄ‡∏Ñ‡∏µ‡∏¢‡∏á‡∏™‡∏≥‡∏Ñ‡∏±‡∏ç‡πÑ‡∏î‡πâ‡πÅ‡∏Å‡πà ‡∏Ñ‡∏•‡∏∑‡πà‡∏ô‡πÑ‡∏™‡πâ ‡∏≠‡∏≤‡πÄ‡∏à‡∏µ‡∏¢‡∏ô ‡∏õ‡∏ß‡∏î‡∏®‡∏£‡∏µ‡∏©‡∏∞ ‡πÄ‡∏ö‡∏∑‡πà‡∏≠‡∏≠‡∏≤‡∏´‡∏≤‡∏£ Sulfasalazine (sulfapyridine + 5-ASA) ‡∏£‡∏∞‡∏ß‡∏±‡∏á‡∏ú‡∏°‡∏£‡πà‡∏ß‡∏á ‡∏ú‡∏∑‡πà‡∏ô‡πÅ‡∏û‡πâ ‡∏£‡∏ß‡∏°‡∏ñ‡∏∂‡∏á ‡∏™‡∏≤‡∏£‡∏Ñ‡∏±‡∏î‡∏´‡∏•‡∏±‡πà‡∏á‡πÄ‡∏õ‡∏•‡∏µ‡πà‡∏¢‡∏ô‡∏™‡∏µ‡∏™‡πâ‡∏° (‡∏ô‡πâ‡∏≥‡∏ï‡∏≤ ‡πÄ‡∏´‡∏á‡∏∑‡πà‡∏≠ ‡∏õ‡∏±‡∏™‡∏™‡∏≤‡∏ß‡∏∞) ‡∏£‡∏∞‡∏ß‡∏±‡∏á anemia thrombocytopenia ‡∏£‡∏∞‡∏ß‡∏±‡∏á‡πÉ‡∏ô‡∏Ñ‡∏ô‡πÅ‡∏û‡πâ sulfa sulfapyridine ‡πÄ‡∏õ‡πá‡∏ô antibiotics ‡πÅ‡∏ï‡πà‡πÄ‡∏£‡∏≤‡∏ô‡∏≥‡∏°‡∏≤‡∏ú‡∏™‡∏°‡πÄ‡∏û‡∏∑‡πà‡∏≠‡πÉ‡∏ä‡πâ‡πÄ‡∏õ‡πá‡∏ô carriers ‡∏°‡∏≤‡∏Å‡∏Å‡∏ß‡πà‡∏≤ ‡πÄ‡∏ô‡∏∑‡πà‡∏≠‡∏á‡∏à‡∏≤‡∏Å‡∏ï‡∏±‡∏ß 5-ASA ‡∏î‡∏π‡∏î‡∏ã‡∏∂‡∏°‡πÑ‡∏î‡πâ‡∏Ñ‡πà‡∏≠‡∏ô‡∏Ç‡πâ‡∏≤‡∏á‡∏ô‡πâ‡∏≠‡∏¢ ‡∏õ‡∏±‡∏à‡∏à‡∏∏‡∏ö‡∏±‡∏ô‡πÄ‡∏£‡∏≤‡∏°‡∏µ mesalamine ‡πÄ‡∏î‡∏µ‡πà‡∏¢‡∏ß ‡∏ó‡∏±‡πâ‡∏á‡πÉ‡∏ô‡∏£‡∏π‡∏õ‡∏Ç‡∏≠‡∏á suppository, enema, oral Corticosteroids ‡∏°‡∏±‡∏Å‡∏à‡∏∞‡πÉ‡∏ä‡πâ‡∏£‡πà‡∏ß‡∏°‡∏Å‡∏±‡∏ö‡∏¢‡∏≤‡∏ï‡∏±‡∏ß‡∏≠‡∏∑‡πà‡∏ô‡∏î‡πâ‡∏ß‡∏¢‡πÄ‡∏™‡∏°‡∏≠ Prednisolone ‡πÉ‡∏ä‡πâ‡πÑ‡∏î‡πâ‡πÅ‡∏Ñ‡πà‡πÉ‡∏ô severe ‡∏õ‡∏Å‡∏ï‡∏¥‡∏à‡∏∞‡πÉ‡∏ä‡πâ‡∏õ‡∏£‡∏∞‡∏°‡∏≤‡∏ì 40-60 mg/d ‡∏õ‡∏£‡∏∞‡∏°‡∏≤‡∏ì 2-3 ‡∏ß‡∏µ‡∏Ñ Budesonide ‡πÉ‡∏ä‡πâ‡πÑ‡∏î‡πâ‡∏ó‡∏±‡πâ‡∏á mild-mod-severe Thiopurine (Azathioprine; pro-drug) ‡∏ï‡πâ‡∏≠‡∏á‡∏ó‡∏î‡∏™‡∏≠‡∏ö TPMT Anti-TNF ‡∏´‡πâ‡∏≤‡∏°‡πÉ‡∏ä‡πâ‡πÉ‡∏ô toxic megacolon ‡πÅ‡∏•‡∏∞‡∏ï‡πâ‡∏≠‡∏á‡πÄ‡∏ä‡πá‡∏Ñ lab TPS, hepatitis Anti-integrin, IL-12, IL-23 inhibitor, JAK inhibitor, Calcineurin inhibitor ‡πÉ‡∏ä‡πâ‡πÉ‡∏ô‡πÄ‡∏Ñ‡∏™‡∏ó‡∏µ‡πà‡πÑ‡∏°‡πà‡∏ï‡∏≠‡∏ö‡∏™‡∏ô‡∏≠‡∏á‡∏ï‡πà‡∏≠ steroid ‡πÅ‡∏•‡∏∞‡∏à‡∏∞‡πÉ‡∏ä‡πâ‡πÅ‡∏Ñ‡πà induction ‡πÄ‡∏û‡∏£‡∏≤‡∏∞ S/E ‡∏Ñ‡πà‡∏≠‡∏ô‡∏Ç‡πâ‡∏≤‡∏á‡πÄ‡∏¢‡∏≠‡∏∞‡∏°‡∏≤‡∏Å ‡πÜ ‡πÅ‡∏ô‡∏ß‡∏ó‡∏≤‡∏á‡∏Å‡∏≤‡∏£‡∏£‡∏±‡∏Å‡∏©‡∏≤ ‡∏à‡∏∏‡∏î‡∏™‡∏±‡∏á‡πÄ‡∏Å‡∏ï: ‡πÉ‡∏ô fulminant ‡∏à‡∏∞‡πÑ‡∏õ‡πÉ‡∏ä‡πâ‡∏û‡∏ß‡∏Å methyprednisolone / hydrocortisone ‡∏Å‡πà‡∏≠‡∏ô ‡∏ñ‡πâ‡∏≤‡∏´‡∏≤‡∏¢‡∏Ñ‡πà‡∏≠‡∏¢‡∏•‡∏î‡πÄ‡∏õ‡πá‡∏ô prednisolone ‡πÉ‡∏ô Cohn Disease ‡∏ñ‡πâ‡∏≤ Severe or Mod ‡∏≠‡∏≤‡∏à‡πÉ‡∏ä‡πâ Prednisolone ‡∏£‡πà‡∏ß‡∏°‡∏Å‡∏±‡∏ö TNF-a inhibitor ‡∏´‡∏£‡∏∑‡∏≠ immunosupressive ‡πÑ‡∏õ‡πÄ‡∏•‡∏¢ !</description></item><item><title/><link>https://quartz.jzhao.xyz/notes/13-Viral-Hepatitis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://quartz.jzhao.xyz/notes/13-Viral-Hepatitis/</guid><description>Upper GI Bleed ‡πÄ‡∏Å‡∏µ‡πà‡∏¢‡∏ß‡∏Ç‡πâ‡∏≠‡∏á‡∏Å‡∏±‡∏ö Hepatitis ‡πÄ‡∏ô‡∏∑‡πà‡∏≠‡∏á‡∏à‡∏≤‡∏Å‡∏™‡∏°‡∏≠‡∏á‡∏°‡∏µ‡∏Ñ‡∏ß‡∏≤‡∏°‡∏™‡∏≥‡∏Ñ‡∏±‡∏ç‡∏Å‡∏ß‡πà‡∏≤‡∏ï‡∏±‡∏ö ‡πÄ‡∏•‡∏∑‡∏≠‡∏î‡∏à‡∏∂‡∏á‡∏≠‡∏≤‡∏à‡πÑ‡∏õ‡πÄ‡∏•‡∏µ‡πâ‡∏¢‡∏á‡∏ó‡∏µ‡πà‡∏ï‡∏±‡∏ö‡∏ô‡πâ‡∏≠‡∏¢‡∏•‡∏á‡πÄ‡∏û‡∏∑‡πà‡∏≠‡∏£‡∏±‡∏Å‡∏©‡∏≤‡πÄ‡∏•‡∏∑‡∏≠‡∏î‡∏ó‡∏µ‡πà‡∏¢‡∏±‡∏á‡πÄ‡∏´‡∏•‡∏∑‡∏≠ ‡∏ó‡∏≥‡πÉ‡∏´‡πâ‡πÄ‡∏Å‡∏¥‡∏î Ischemia ‡∏ó‡∏µ‡πà‡∏ï‡∏±‡∏ö‡πÑ‡∏î‡πâ ‡∏ô‡∏≠‡∏Å‡∏à‡∏≤‡∏Å Blood circulation ‡∏•‡∏î‡∏•‡∏á ‡∏Å‡πá‡∏≠‡∏≤‡∏à‡∏°‡∏≤‡∏à‡∏≤‡∏Å‡∏™‡∏≤‡∏£‡∏û‡∏¥‡∏©‡πÄ‡∏ä‡πà‡∏ô alpha-toxin ‡∏´‡∏£‡∏∑‡∏≠ autoimmune disease ‡∏ï‡πà‡∏≤‡∏á ‡πÜ ‡∏´‡∏£‡∏∑‡∏≠‡∏Å‡∏≤‡∏£‡∏ï‡∏¥‡∏î‡πÄ‡∏ä‡∏∑‡πâ‡∏≠‡∏ï‡πà‡∏≤‡∏á ‡πÜ Acute (&amp;lt; 6 months) Viral hepatitis A,E ‡∏°‡∏±‡∏Å‡∏°‡∏≤‡∏î‡πâ‡∏ß‡∏¢‡∏≠‡∏≤‡∏Å‡∏≤‡∏£ Abdominal Pain ‡∏£‡πà‡∏≤‡∏á‡∏Å‡∏≤‡∏¢‡∏Ç‡∏±‡∏ö bilirubin ‡πÑ‡∏°‡πà‡πÑ‡∏î‡πâ ‡∏à‡∏∂‡∏á‡πÑ‡∏°‡πà‡∏≠‡∏≠‡∏Å‡∏ó‡∏≤‡∏á‡∏≠‡∏∏‡∏à‡∏≤‡∏£‡∏∞‡πÄ‡∏•‡∏¢ ‡πÅ‡∏•‡∏∞‡πÑ‡∏õ‡∏≠‡∏≠‡∏Å‡∏ó‡∏≤‡∏á‡∏õ‡∏±‡∏™‡∏™‡∏≤‡∏ß‡∏∞‡πÅ‡∏ó‡∏ô -&amp;gt; dark urine, jaundice hepatomegaly Chronic (&amp;gt; 6 months) Viral hepatitis B,C,D Non-alcoholic fatty liver disease (NAFLD) ‡∏´‡∏£‡∏∑‡∏≠ ‡πÑ‡∏Ç‡∏°‡∏±‡∏ô‡∏û‡∏≠‡∏Å‡∏ï‡∏±‡∏ö hepatomegaly ‡∏™‡∏£‡πâ‡∏≤‡∏á albumin ‡πÑ‡∏î‡πâ‡∏ô‡πâ‡∏≠‡∏¢ ‡∏£‡πà‡∏≤‡∏á‡∏Å‡∏≤‡∏¢‡∏à‡∏∂‡∏á‡∏î‡∏∂‡∏á‡∏ô‡πâ‡∏≥‡πÑ‡∏î‡πâ‡∏ô‡πâ‡∏≠‡∏¢ ‡∏ó‡∏≥‡πÉ‡∏´‡πâ‡πÄ‡∏Å‡∏¥‡∏î peripheral oedema, ascites, cirrhosis cirrhosis ‡∏°‡∏≤‡∏à‡∏≤‡∏Å‡∏Å‡∏≤‡∏£‡∏ó‡∏µ‡πà‡πÄ‡∏ã‡∏•‡∏•‡πå‡∏ï‡∏±‡∏ö‡∏ñ‡∏π‡∏Å‡πÅ‡∏ó‡∏ô‡∏ó‡∏µ‡πà‡∏î‡πâ‡∏ß‡∏¢ fibrous A B C D E acute only 5-10% chronic 80% chronic -&amp;gt; easily cancer 5% chronic acute only RNA naked -&amp;gt; ‡∏ó‡∏ô fecal/oral ‡πÑ‡∏î‡πâ sex/parenteral sex/parenteral sex/parenteral RNA naked -&amp;gt; ‡∏ó‡∏ô fecal/oral ‡πÑ‡∏î‡πâ ‡πÄ‡∏õ‡πá‡∏ô‡∏ï‡∏±‡∏ß‡πÄ‡∏î‡∏µ‡∏¢‡∏ß‡∏ó‡∏µ‡πà‡πÄ‡∏õ‡πá‡∏ô DNA enveloped RNA enveloped enveloped but incomplete ‡∏ï‡πâ‡∏≠‡∏á‡∏Å‡∏≤‡∏£ HbsAg serology ‡∏û‡∏ö HbsAg, HbsAb, HBeAb HBeAg ‡∏ñ‡πâ‡∏≤‡∏´‡∏≤‡∏Å‡∏ï‡∏¥‡∏î D -&amp;gt; ‡∏ï‡∏¥‡∏î B ‡∏î‡πâ‡∏ß‡∏¢‡πÅ‡∏ô‡πà ‡πÜ</description></item><item><title/><link>https://quartz.jzhao.xyz/notes/14-Alcoholic-hepatitis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://quartz.jzhao.xyz/notes/14-Alcoholic-hepatitis/</guid><description>Alcoholic 80% ‡∏à‡∏∞‡∏°‡∏µ fatty liver -&amp;gt; 20-40% fibrosis -&amp;gt; 10-20% cirrhosis ‡πÅ‡∏•‡∏∞ 1-2% of cirrhosis ‡∏à‡∏∞‡πÄ‡∏õ‡πá‡∏ô HCC</description></item><item><title/><link>https://quartz.jzhao.xyz/notes/15-Cirrhosis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://quartz.jzhao.xyz/notes/15-Cirrhosis/</guid><description>Risk Factors HCV HBV ‡∏õ‡∏•. hepatitis ‡πÑ‡∏°‡πà‡πÑ‡∏î‡πâ‡πÅ‡∏õ‡∏•‡∏ß‡πà‡∏≤‡∏à‡∏∞‡∏ï‡πâ‡∏≠‡∏á‡∏à‡∏ö‡∏ó‡∏µ‡πà cirrhosis ‡πÄ‡∏™‡∏°‡∏≠‡πÑ‡∏õ! NAFLD or Alcohol Pathophysiology ‡∏Å‡∏≤‡∏£‡∏≠‡∏±‡∏Å‡πÄ‡∏™‡∏ö‡πÄ‡∏£‡∏∑‡πâ‡∏≠‡∏£‡∏±‡∏á ‡∏à‡∏ô‡πÄ‡∏Å‡∏¥‡∏î‡∏û‡∏±‡∏á‡∏ú‡∏∑‡∏î ‡∏ô‡∏≥‡πÑ‡∏õ‡∏™‡∏π‡πà‡∏†‡∏≤‡∏ß‡∏∞‡∏ï‡∏±‡∏ö‡πÅ‡∏Ç‡πá‡∏á ‡∏†‡∏≤‡∏ß‡∏∞‡∏ï‡∏±‡∏ö‡πÅ‡∏Ç‡πá‡∏á ‡∏ó‡∏≥‡πÉ‡∏´‡πâ‡πÄ‡∏Å‡∏¥‡∏î‡∏†‡∏≤‡∏ß‡∏∞ (‡∏ó‡∏µ‡πà‡∏ó‡∏≥‡∏ï‡∏±‡∏ß‡∏´‡∏ô‡∏≤ (bold) ‡∏´‡∏°‡∏≤‡∏¢‡∏ñ‡∏∂‡∏á‡πÄ‡∏õ‡πá‡∏ô‡∏™‡∏≤‡πÄ‡∏´‡∏ï‡∏∏‡∏´‡∏•‡∏±‡∏Å‡πÉ‡∏ô‡∏Å‡∏≤‡∏£‡πÄ‡∏™‡∏µ‡∏¢‡∏ä‡∏µ‡∏ß‡∏¥‡∏ï ‡∏Ñ‡∏ß‡∏≤‡∏°‡∏î‡∏±‡∏ô‡πÉ‡∏ô‡∏ï‡∏±‡∏ö‡∏™‡∏π‡∏á ascites varices - SBP ‡∏Å‡∏≤‡∏£‡∏ó‡∏≥‡∏á‡∏≤‡∏ô‡∏Ç‡∏≠‡∏á‡∏ï‡∏±‡∏ö‡∏•‡∏î‡∏•‡∏á coagulopathy - variceal bleeding hepatic encephalopathy ‡∏†‡∏≤‡∏ß‡∏∞ cirrhosis ‡∏à‡∏∞‡∏°‡∏µ‡∏û‡∏ß‡∏Å fibrous septum ‡∏°‡∏≤‡πÅ‡∏ó‡∏£‡∏Å ‡∏ó‡∏≥‡πÉ‡∏´‡πâ‡∏Å‡∏≤‡∏£ metabolism ‡∏™‡∏≤‡∏£‡∏ï‡πà‡∏≤‡∏á ‡πÜ ‡πÄ‡∏õ‡πá‡∏ô‡πÑ‡∏õ‡πÑ‡∏î‡πâ‡∏¢‡∏≤‡∏Å‡∏Ç‡∏∂‡πâ‡∏ô ‡πÅ‡∏•‡∏∞‡∏¢‡∏±‡∏á‡∏°‡∏µ fatty cysts ‡∏°‡∏≤‡πÅ‡∏ó‡∏£‡∏Å‡∏≠‡∏µ‡∏î‡πâ‡∏ß‡∏¢ Symptoms ‡∏ï‡∏≤‡∏°‡∏£‡∏∞‡∏ö‡∏ö‡∏≠‡∏ß‡∏±‡∏¢‡∏ß‡∏∞‡∏ï‡πà‡∏≤‡∏á ‡πÜ Neurologic Hepatic encephalopathy Peripheral neuropathy (‡πÄ‡∏û‡∏£‡∏≤‡∏∞‡∏Å‡∏≤‡∏£ abs vit B ‡∏•‡∏î‡∏•‡∏á) Gastrointestinal varices Reproductive ‡∏Å‡∏î GnRH ‡πÑ‡∏î‡πâ ‡∏ó‡∏≥‡πÉ‡∏´‡πâ‡πÄ‡∏Å‡∏¥‡∏î‡∏õ‡∏±‡∏ç‡∏´‡∏≤‡∏ó‡∏≤‡∏á‡∏î‡πâ‡∏≤‡∏ô sex ‡∏ï‡πà‡∏≤‡∏á ‡πÜ ‡∏ï‡∏≤‡∏°‡∏°‡∏≤ ‡πÅ‡∏•‡∏∞‡∏¢‡∏±‡∏á‡∏°‡∏µ gynecomastia (male) ‡πÄ‡∏Å‡∏¥‡∏î‡∏Ç‡∏∂‡πâ‡∏ô‡πÑ‡∏î‡πâ‡∏≠‡∏µ‡∏Å Integumentary jaundice ‡πÅ‡∏•‡∏∞‡∏Å‡πá‡∏û‡∏ß‡∏Å‡∏ú‡∏∑‡πà‡∏ô ‡πÜ ‡∏ï‡πà‡∏≤‡∏á ‡πÜ ‡πÄ‡∏ä‡πà‡∏ô spider angioma, petechiae, purpura Hematologic Anemia of chronic disease thrombocytopenia leukopenia Portal Hypertension !</description></item><item><title/><link>https://quartz.jzhao.xyz/notes/16-DIGI/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://quartz.jzhao.xyz/notes/16-DIGI/</guid><description>Gingival Enlargement Phenytoin DHP-CCBs (‡∏û‡∏ß‡∏Å amlodipine) Cyclosporin Oropharyngeal Candidiasis ‡∏à‡∏≤‡∏Å‡∏Å‡∏≤‡∏£‡∏Å‡∏î‡∏†‡∏π‡∏°‡∏¥‡∏Ñ‡∏∏‡πâ‡∏°‡∏Å‡∏±‡∏ô ‡∏ó‡∏±‡πâ‡∏á systemic ‡πÅ‡∏•‡∏∞ locally ‡πÉ‡∏ä‡πâ genteal violet, fluconazole oral or clotrimazole oral ‡∏£‡∏±‡∏Å‡∏©‡∏≤ Oral lichen planus ‡∏õ‡∏è‡∏¥‡∏Å‡∏¥‡∏£‡∏¥‡∏¢‡∏≤‡∏†‡∏π‡∏°‡∏¥‡∏Ñ‡∏∏‡πâ‡∏°‡∏Å‡∏±‡∏ô metoprolol imatinib ticlopidine Pill esophagitis ‡∏Å‡∏≤‡∏£‡∏£‡∏∞‡∏Ñ‡∏≤‡∏¢‡πÄ‡∏Ñ‡∏∑‡∏≠‡∏á‡∏à‡∏≤‡∏Å‡∏¢‡∏≤‡∏ó‡∏µ‡πà‡πÄ‡∏õ‡πá‡∏ô‡∏Ç‡∏≠‡∏á‡πÅ‡∏Ç‡πá‡∏á ‡∏Ñ‡∏∏‡∏ì‡∏™‡∏°‡∏ö‡∏±‡∏ï‡∏¥‡∏ó‡∏≤‡∏á‡πÄ‡∏Ñ‡∏°‡∏µ‡∏Ç‡∏≠‡∏á‡∏¢‡∏≤ ‡∏≠‡∏≤‡∏à‡πÄ‡∏™‡∏£‡∏¥‡∏° ‡πÄ‡∏ä‡πà‡∏ô Bisphosphonate, quinidine, tetracycline, potassium chloride, iron suppl, NSAIDs ‡πÅ‡∏Å‡πâ‡∏î‡πâ‡∏ß‡∏¢‡∏Å‡∏≤‡∏£‡∏î‡∏∑‡πà‡∏°‡∏ô‡πâ‡∏≥‡πÄ‡∏¢‡∏≠‡∏∞ ‡πÜ ‡πÇ‡∏î‡∏¢‡∏î‡∏∑‡πà‡∏°‡∏Å‡πà‡∏≠‡∏ô‡∏Å‡∏¥‡∏ô‡∏ô‡∏¥‡∏î‡∏ô‡∏∂‡∏á (hydrate ‡∏´‡∏•‡∏≠‡∏î‡∏≠‡∏≤‡∏´‡∏≤‡∏£) ‡πÅ‡∏•‡πâ‡∏ß‡∏î‡∏∑‡πà‡∏°‡πÄ‡∏¢‡∏≠‡∏∞ ‡πÜ ‡∏ï‡∏≤‡∏°‡∏ó‡∏µ‡∏´‡∏•‡∏±‡∏á ‡∏´‡∏•‡∏±‡∏á‡∏Å‡∏¥‡∏ô GERD Lower ESP CCB ‡∏ó‡∏±‡πâ‡∏á‡∏™‡∏≠‡∏á‡∏Å‡∏•‡∏∏‡πà‡∏° opiate TCA BZ ‡∏û‡∏ß‡∏Å b-block b a-agonist a-block Irritate mucosa nsaids, tetracycline, bisphosphonate NSAIDs Gastropathy !</description></item><item><title/><link>https://quartz.jzhao.xyz/notes/17-DILI/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://quartz.jzhao.xyz/notes/17-DILI/</guid><description>Toxicity 10-20% of acute liver failure are associated with DILI ‡∏°‡∏µ‡∏´‡∏•‡∏≤‡∏¢‡∏Å‡∏•‡πÑ‡∏Å‡∏°‡∏≤‡∏Å ‡πÜ ‡πÄ‡∏ä‡πà‡∏ô oxidative stress, mitochondrial impairment mostly type A ADR ‡πÅ‡∏•‡∏∞‡∏õ‡πâ‡∏≠‡∏á‡∏Å‡∏±‡∏ô‡πÑ‡∏î‡πâ ‡πÅ‡∏ï‡πà‡∏Ñ‡∏≤‡∏î‡πÄ‡∏î‡∏≤‡∏¢‡∏≤‡∏Å‡πÄ‡∏û‡∏£‡∏≤‡∏∞‡∏õ‡∏±‡∏à‡∏à‡∏±‡∏¢‡∏ó‡∏≤‡∏á genetic ‡∏ó‡∏µ‡πà‡∏°‡∏µ‡∏Ñ‡∏ß‡∏≤‡∏° polymorph ‡∏™‡∏π‡∏á WHO Definition of Hepatotoxicity Grade ALT Criteria Grade 1 (mild) &amp;lt; 2.</description></item><item><title/><link>https://quartz.jzhao.xyz/notes/18-Drug-dosing-in-liver-impairment/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://quartz.jzhao.xyz/notes/18-Drug-dosing-in-liver-impairment/</guid><description>Child-Pugh ‡πÉ‡∏ä‡πâ‡∏õ‡∏£‡∏∞‡πÄ‡∏°‡∏¥‡∏ô prognosis ‡∏°‡∏≤‡∏Å‡∏Å‡∏ß‡πà‡∏≤ ‡πÑ‡∏°‡πà‡πÑ‡∏î‡πâ‡∏ö‡πà‡∏á‡∏ö‡∏≠‡∏Å‡∏Ñ‡∏ß‡∏≤‡∏°‡∏™‡∏≤‡∏°‡∏≤‡∏£‡∏ñ‡∏î‡πâ‡∏≤‡∏ô synthesis ‡πÅ‡∏•‡∏∞ conjugation A (5-6) -&amp;gt; life expectancy 10-20 yr, mortality ‡∏ô‡πâ‡∏≠‡∏¢ B (7-9) -&amp;gt; candidate for transplant, 30% mortality perioperative C (10-15) -&amp;gt; 1-3 yrs-&amp;gt; 82% mortality perioperative !</description></item><item><title/><link>https://quartz.jzhao.xyz/notes/2-COPD-2022/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://quartz.jzhao.xyz/notes/2-COPD-2022/</guid><description>‡∏°‡∏µ‡∏Å‡∏≤‡∏£‡∏ó‡∏≥ Taxonomy by Etiotypes COPD-G (alpha-1 antitrypsin deficiency) COPD-I (copd from infections) COPD-A (copd &amp;amp; asthma) ‡πÉ‡∏ô GINA ‡∏à‡∏∞‡πÄ‡∏õ‡πá‡∏ô‡∏≠‡∏µ‡∏Å‡∏Ç‡∏∑‡πà‡∏≠ : asthma overlap COPD Clinical Indicators Dypsnea ‡∏ó‡∏µ‡πà progessive, worsen with exercise, persistent Recurrent Wheeze Chronic Cough GOLD Grade (post bronco FEV1) ‡∏ö‡πà‡∏á‡∏ö‡∏≠‡∏Å‡∏Ñ‡∏ß‡∏≤‡∏°‡∏£‡∏∏‡∏ô‡πÅ‡∏£‡∏á‡∏Ç‡∏≠‡∏á‡∏Å‡∏≤‡∏£‡∏≠‡∏∏‡∏î‡∏ï‡∏±‡πâ‡∏ô Memo: 80 50 30 30 ‡πÄ‡∏Å‡∏£‡∏î‡∏™‡∏π‡∏á‡∏¢‡∏¥‡πà‡∏á‡∏´‡∏ô‡∏±‡∏Å !</description></item><item><title/><link>https://quartz.jzhao.xyz/notes/20-Synovial-Analysis/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://quartz.jzhao.xyz/notes/20-Synovial-Analysis/</guid><description>Definitions mixture of protein-rich ultrafiltrate of plasma and hyaluronan synthesized by synoviocytes functions: to aid in nutrition and mechanical function ‡∏Å‡∏≤‡∏£‡πÄ‡∏à‡∏≤‡∏∞‡∏ô‡πâ‡∏≥‡πÉ‡∏ô‡∏Ç‡πâ‡∏≠‡πÄ‡∏£‡∏µ‡∏¢‡∏Å‡∏ß‡πà‡∏≤ arthrocentesis ‡∏õ‡∏Å‡∏ï‡∏¥‡∏´‡∏°‡∏≠‡∏à‡∏∞‡∏ï‡πâ‡∏≠‡∏á‡∏î‡∏π‡∏ï‡∏≥‡πÅ‡∏´‡∏ô‡πà‡∏á‡πÄ‡∏à‡∏≤‡∏∞‡πÄ‡∏≠‡∏á / ‡∏Å‡∏≤‡∏£‡πÉ‡∏ä‡πâ U/S sound ‡πÑ‡∏°‡πà‡πÉ‡∏ä‡πà standard Normal SF (Class I) ‡∏°‡∏±‡∏Å‡πÄ‡∏à‡∏≠‡πÉ‡∏ô OA, trauma (‡πÄ‡∏û‡∏£‡∏≤‡∏∞‡∏°‡∏±‡∏ô‡∏°‡∏±‡∏Å‡∏à‡∏∞‡πÑ‡∏°‡πà inflammation) ‡∏à‡∏∞‡∏ï‡πâ‡∏≠‡∏á‡πÉ‡∏™‡πà clear (transparaent; ‡∏≠‡πà‡∏≤‡∏ô‡∏ï‡∏±‡∏ß‡∏´‡∏ô‡∏±‡∏á‡∏™‡∏∑‡∏≠‡πÑ‡∏î‡πâ) ‡∏™‡∏µ‡πÉ‡∏™‡∏´‡∏£‡∏∑‡∏≠‡πÄ‡∏´‡∏•‡∏∑‡∏≠‡∏á ‡∏õ‡∏£‡∏¥‡∏°‡∏≤‡∏ì &amp;lt; 3.</description></item><item><title/><link>https://quartz.jzhao.xyz/notes/21-OA/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://quartz.jzhao.xyz/notes/21-OA/</guid><description>Definitions ‡πÄ‡∏õ‡πá‡∏ô‡πÇ‡∏£‡∏Ñ progressive ‡∏ó‡∏µ‡πà‡∏Ç‡πâ‡∏≠‡πÄ‡∏™‡∏∑‡πà‡∏≠‡∏°‡∏•‡∏á‡∏≠‡∏¢‡πà‡∏≤‡∏á‡∏ï‡πà‡∏≠‡πÄ‡∏ô‡∏∑‡πà‡∏≠‡∏á ‡∏û‡∏ö‡πÄ‡∏à‡∏≠‡πÑ‡∏î‡πâ‡∏ó‡∏µ‡πà‡πÄ‡∏Ç‡πà‡∏≤ ‡πÅ‡∏ï‡πà‡πÑ‡∏°‡πà‡πÑ‡∏î‡πâ‡∏à‡∏≥‡πÄ‡∏õ‡πá‡∏ô‡∏ï‡πâ‡∏≠‡∏á‡πÄ‡∏õ‡πá‡∏ô‡∏ó‡∏µ‡πà‡πÄ‡∏Ç‡πà‡∏≤ ‡∏°‡∏µ‡∏Å‡∏≤‡∏£‡∏ó‡∏≥‡∏•‡∏≤‡∏¢‡∏Å‡∏£‡∏∞‡∏î‡∏π‡∏Å‡∏≠‡πà‡∏≠‡∏ô‡∏ú‡∏¥‡∏ß‡∏Ç‡πâ‡∏≠ ‡∏°‡∏µ‡∏Ç‡∏≠‡∏ö‡∏Å‡∏£‡∏∞‡∏î‡∏π‡∏Å‡πÉ‡∏ô‡∏Ç‡πâ‡∏≠‡∏´‡∏ô‡∏≤‡∏ï‡∏±‡∏ß‡∏Ç‡∏∂‡πâ‡∏ô ‡∏ô‡πâ‡∏≥‡πÉ‡∏ô‡∏Ç‡πâ‡∏≠‡πÄ‡∏õ‡∏•‡∏µ‡πà‡∏¢‡∏ô‡∏ô‡∏¥‡∏î‡∏´‡∏ô‡πà‡∏≠‡∏¢‡∏ó‡∏≥‡πÉ‡∏´‡πâ‡∏´‡∏•‡πà‡∏≠‡∏•‡∏∑‡πà‡∏ô‡πÑ‡∏î‡πâ‡∏ô‡πâ‡∏≠‡∏¢‡∏•‡∏á Epidemiology top 10 ‡∏Ç‡∏≠‡∏á‡πÇ‡∏£‡∏Ñ‡∏ó‡∏µ‡πà‡∏ó‡∏≥‡πÉ‡∏´‡πâ‡πÄ‡∏Å‡∏¥‡∏î‡∏Å‡∏≤‡∏£‡∏û‡∏¥‡∏Å‡∏≤‡∏£‡πÉ‡∏ô‡πÑ‡∏ó‡∏¢ 55 ‡∏õ‡∏µ‡πÄ‡∏£‡∏¥‡πà‡∏°‡∏°‡∏µ‡∏Ñ‡∏ß‡∏≤‡∏°‡πÄ‡∏™‡∏µ‡πà‡∏¢‡∏á‡πÅ‡∏•‡πâ‡∏ß ‡πÅ‡∏ï‡πà‡∏≠‡∏à.‡πÉ‡∏ä‡πâ‡∏ï‡∏±‡∏ß‡πÄ‡∏•‡∏Ç 45 Pathophysiology cartilage ‡∏õ‡∏£‡∏∞‡∏Å‡∏≠‡∏ö‡πÑ‡∏õ‡∏î‡πâ‡∏ß‡∏¢ hyaluronic acid (2-4 mg/ml), collagen, proteoglycan, chondroitin ‡πÅ‡∏•‡∏∞‡∏°‡∏µ synovial fluid ‡∏ä‡πà‡∏ß‡∏¢‡∏´‡∏•‡πà‡∏≠‡∏•‡∏∑‡πà‡∏ô ‡∏´‡∏≤‡∏Å‡∏™‡∏¥‡πà‡∏á‡πÉ‡∏î‡∏™‡∏¥‡πà‡∏á‡∏´‡∏ô‡∏∂‡πà‡∏á‡πÄ‡∏™‡∏∑‡πà‡∏≠‡∏°‡∏™‡∏†‡∏≤‡∏û‡∏Å‡πá‡∏à‡∏∞‡πÄ‡∏Å‡∏¥‡∏î‡∏õ‡∏±‡∏ç‡∏´‡∏≤‡∏ï‡∏≤‡∏°‡∏°‡∏≤‡πÑ‡∏î‡πâ !</description></item><item><title/><link>https://quartz.jzhao.xyz/notes/22-RA/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://quartz.jzhao.xyz/notes/22-RA/</guid><description>Introduction ‡πÇ‡∏£‡∏Ñ‡∏Ç‡πâ‡∏≠‡∏ó‡∏µ‡πà chronic, progressive, autoimmune ‡πÄ‡∏õ‡πá‡∏ô‡πÇ‡∏£‡∏Ñ‡∏ó‡∏µ‡πà symmetry ‡πÅ‡∏•‡∏∞‡∏°‡∏µ‡∏ú‡∏•‡∏ï‡πà‡∏≠ synovium ‡∏Ç‡∏≠‡∏á‡∏Ç‡πâ‡∏≠ ‡∏°‡∏µ‡∏≠‡∏≤‡∏Å‡∏≤‡∏£ extra-articular involvement ‡∏´‡∏•‡∏≤‡∏Å‡∏´‡∏•‡∏≤‡∏¢ ^14dfb0 ‡∏ï‡∏≤: vasculitis skin: rheumatoid nodule 40-50% ‡∏û‡∏¥‡∏Å‡∏≤‡∏£‡πÉ‡∏ô 5 ‡∏õ‡∏µ‡∏ñ‡πâ‡∏≤‡πÑ‡∏°‡πà‡∏£‡∏±‡∏Å‡∏©‡∏≤ Risk Factors 60% genetics epigenetic modification susceptibility genes 40% non-genetic Pathophysiology ‡∏£‡∏∞‡∏¢‡∏∞‡πÅ‡∏£‡∏Å ‡πÜ (preclinical RA) ‡∏≠‡∏≤‡∏à‡πÄ‡∏Å‡∏¥‡∏î citrullination ‡∏´‡∏•‡∏±‡∏á‡∏à‡∏≤‡∏Å‡∏ô‡∏±‡πâ‡∏ô‡∏°‡∏µ‡∏Å‡∏≤‡∏£‡∏™‡∏£‡πâ‡∏≤‡∏á autoantibody ‡πÅ‡∏•‡πâ‡∏ß infiltrate ‡πÄ‡∏Ç‡πâ‡∏≤‡πÑ‡∏õ‡πÉ‡∏ô‡∏ö‡∏£‡∏¥‡πÄ‡∏ß‡∏ì‡∏Ç‡πâ‡∏≠ (early RA) autoantibodies ‡πÄ‡∏ä‡πà‡∏ô APCAs ‡πÅ‡∏•‡∏∞ RF ‡∏à‡∏ô‡∏™‡∏∏‡∏î‡∏ó‡πâ‡∏≤‡∏¢ shape ‡πÄ‡∏õ‡∏•‡∏µ‡πà‡∏¢‡∏ô (established RA) Staging Synovitis synovial membrane ‡∏≠‡∏±‡∏Å‡πÄ‡∏™‡∏ö‡πÄ‡∏â‡∏¢ ‡πÜ Pannus ‡πÄ‡∏Å‡∏¥‡∏î pannus ‡∏à‡∏≤‡∏Å‡∏Å‡∏≤‡∏£‡∏ó‡∏µ‡πà‡∏°‡∏±‡∏ô‡πÇ‡∏î‡∏ô attack / ‡∏ï‡∏±‡∏ß cartilage ‡∏™‡∏π‡∏ç‡πÄ‡∏™‡∏µ‡∏¢‡πÑ‡∏õ‡πÄ‡∏¢‡∏≠‡∏∞ ‡∏Ñ‡∏ô‡πÑ‡∏Ç‡πâ‡∏°‡∏±‡∏Å CC ‡∏°‡∏≤‡πÉ‡∏ô stage ‡∏ô‡∏µ‡πâ Fibrous ankylosis ‡∏ï‡∏±‡∏ß fibrous connective tissue invade ‡∏ï‡∏±‡∏ß‡∏ß synovial Bony ankylosis ‡∏Å‡∏£‡∏∞‡∏î‡∏π‡∏Å‡πÄ‡∏ä‡∏∑‡πà‡∏≠‡∏°‡∏Å‡∏±‡∏ô Clinical Features prolonged morning stiffness more than 30 mins ‡∏≠‡∏≤‡∏à‡∏à‡∏∞‡∏õ‡∏ß‡∏î ‡∏´‡∏£‡∏∑‡∏≠‡πÑ‡∏°‡πà‡∏õ‡∏ß‡∏î‡∏Å‡πá‡πÑ‡∏î‡πâ !</description></item><item><title/><link>https://quartz.jzhao.xyz/notes/23-Drug-Induced-bone-joint-muscle-disease/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://quartz.jzhao.xyz/notes/23-Drug-Induced-bone-joint-muscle-disease/</guid><description>Osteoporosis, Osteomalacia Cause: Primary (aging, deceased gonadal function in early menopause), Secondary (exposure, medical disorders) ‡πÇ‡∏£‡∏Ñ‡∏Å‡∏£‡∏∞‡∏î‡∏π‡∏Å‡∏ô‡πà‡∏ß‡∏°: ‡∏Å‡∏£‡∏∞‡∏î‡∏π‡∏Å‡πÅ‡∏Ç‡πá‡∏á‡∏≠‡πà‡∏≠‡∏ô ‡πÇ‡∏Ñ‡πâ‡∏á‡∏á‡∏≠‡πÑ‡∏î‡πâ ‡πÄ‡∏Å‡∏¥‡πÄ‡∏î‡∏à‡∏≤‡∏Å‡∏Ñ‡∏ß‡∏≤‡∏°‡∏ú‡∏¥‡∏î‡∏õ‡∏Å‡∏ï‡∏¥‡πÉ‡∏ô‡∏Å‡∏≤‡∏£‡πÄ‡∏Å‡∏¥‡∏î mineralization ‡∏Ç‡∏≠‡∏á osteoid ‡∏°‡∏≤‡∏à‡∏≤‡∏Å‡∏Å‡∏≤‡∏£‡∏Ç‡∏≤‡∏î vitamin D ‡∏´‡∏£‡∏∑‡∏≠‡πÉ‡∏ô‡πÄ‡∏î‡πá‡∏Å growth plate ‡πÄ‡∏Å‡∏¥‡∏î mineralization ‡∏ú‡∏¥‡∏î‡∏õ‡∏Å‡∏ï‡∏¥ ‡πÄ‡∏£‡∏µ‡∏¢‡∏Å rickets (juvenile osteomalacia) steroid ‡∏ä‡∏±‡∏î‡∏™‡∏∏‡∏î ‡πÄ‡∏û‡∏¥‡πà‡∏°‡∏Å‡∏≤‡∏£‡∏Ñ‡∏•‡∏≤‡∏¢‡∏Å‡∏£‡∏∞‡∏î‡∏π‡∏Å ‡∏•‡∏î‡∏Å‡∏≤‡∏£‡∏™‡∏£‡πâ‡∏≤‡∏á‡∏Å‡∏£‡∏∞‡∏î‡∏π‡∏Å ‡∏•‡∏î‡∏Å‡∏≤‡∏£‡∏î‡∏π‡∏î‡∏ã‡∏∂‡∏°‡πÅ‡∏Ñ‡∏•‡πÄ‡∏ã‡∏µ‡∏¢‡∏° ‡πÄ‡∏û‡∏¥‡πà‡∏°‡∏Å‡∏≤‡∏£ express ‡∏Ç‡∏≠‡∏á RANKL dose and duration dependent, higher cumulative exposure antiepileptics phenytoin, CBZ, phenobarbital ‡πÄ‡∏õ‡πá‡∏ô cyp inducer ‡∏ó‡∏≥‡πÉ‡∏´‡πâ vit d metabolism ‡∏™‡∏π‡∏á‡∏Ç‡∏∂‡πâ‡∏ô ‡∏°‡∏µ‡∏õ‡∏£‡∏¥‡∏°‡∏≤‡∏ì‡πÉ‡∏ô‡πÄ‡∏•‡∏∑‡∏≠‡∏î‡∏•‡∏î‡∏•‡∏á ‡∏ó‡∏≥‡πÉ‡∏´‡πâ‡∏Å‡∏≤‡∏£‡∏î‡∏π‡∏î‡∏ã‡∏∂‡∏°‡πÅ‡∏Ñ‡∏•‡πÄ‡∏ã‡∏µ‡∏¢‡∏°‡∏•‡∏î‡∏•‡∏á -&amp;gt; vit D def and osteomalacia valproic acid ‡πÄ‡∏û‡∏¥‡πà‡∏°‡∏Å‡∏≤‡∏£‡∏Ç‡∏±‡∏ö‡πÅ‡∏Ñ‡∏•‡πÄ‡∏ã‡∏µ‡∏¢‡∏°‡πÅ‡∏•‡∏∞‡∏ü‡∏≠‡∏™‡∏ü‡∏≠‡∏£‡∏±‡∏™ -&amp;gt; osteomalacia levetiracetam -&amp;gt; no report but ‡∏Ç‡πâ‡∏≠‡∏°‡∏π‡∏•‡∏î‡∏π‡∏î‡∏µ‡∏ß‡πà‡∏≤‡∏ó‡∏≥‡πÉ‡∏´‡πâ BMD ‡∏î‡∏µ‡∏Ç‡∏∂‡πâ‡∏ô antiretroviral therapy NRTIs &amp;gt; PIs TDF &amp;gt; other NRTI RTV &amp;gt; other PIs ‡πÄ‡∏û‡∏¥‡πà‡∏°‡∏Å‡∏≤‡∏£‡∏™‡∏•‡∏≤‡∏¢‡∏Å‡∏£‡∏∞‡∏î‡∏π‡∏Å‡πÅ‡∏•‡∏∞‡∏•‡∏î‡∏Å‡∏≤‡∏£‡∏™‡∏£‡πâ‡∏≤‡∏á Antineoplastic agents ‡∏Ñ‡∏•‡πâ‡∏≤‡∏¢ primary osteoporosis ‡∏Å‡∏î‡∏Å‡∏≤‡∏£‡∏ó‡∏≥‡∏á‡∏≤‡∏ô‡∏Ç‡∏≠‡∏á gonadal function renal phosphate wasting leading to osteomalacia and bone loss aromatase inhibitors ‡∏¢‡∏±‡∏ö‡∏¢‡∏±‡πâ‡∏á‡∏Å‡∏≤‡∏£‡πÄ‡∏õ‡∏•‡∏µ‡πà‡∏¢‡∏ô peripheral androgen to estrogen depot medroxyprogesterone suppress HPA axis ‡∏ó‡∏≥‡πÉ‡∏´‡πâ‡∏•‡∏î estrogen gonadotropin releasing hormone agonist ‡∏•‡∏î‡∏Å‡∏≤‡∏£‡∏ú‡∏•‡∏¥‡∏ï sex hormone SGLT2 inhibitor canagliflozin ‡πÄ‡∏û‡∏¥‡πà‡∏° risk ‡πÅ‡∏ï‡πà‡∏ï‡∏±‡∏ß‡∏≠‡∏∑‡πà‡∏ô‡∏¢‡∏±‡∏á‡πÑ‡∏°‡πà‡∏°‡∏µ‡∏Ç‡πâ‡∏≠‡∏°‡∏π‡∏•‡∏ä‡∏±‡∏î‡πÄ‡∏à‡∏ô ‡πÄ‡∏Å‡∏¥‡∏î‡∏à‡∏≤‡∏Å‡∏Å‡∏≤‡∏£‡πÄ‡∏û‡∏¥‡πà‡∏° PTH ‡∏ó‡∏≥‡πÉ‡∏´‡πâ‡πÄ‡∏Å‡∏¥‡∏î bone resorption TZD decrease osteoblastogenesis Furosemide ‡πÄ‡∏û‡∏¥‡πà‡∏°‡∏Å‡∏≤‡∏£‡∏Ç‡∏±‡∏ö calcium PPI ‡πÑ‡∏°‡πà‡∏ó‡∏£‡∏≤‡∏ö mech ‡πÅ‡∏ï‡πà‡πÄ‡∏û‡∏¥‡πà‡∏° fracture ‡πÅ‡∏ô‡πà ‡πÜ ‡∏™‡πà‡∏ß‡∏ô BMD ‡πÑ‡∏°‡πà‡πÅ‡∏ô‡πà‡πÉ‡∏à high-dose long-term heparin fracture ‡πÑ‡∏î‡πâ‡∏™‡∏π‡∏á‡∏Å‡∏ß‡πà‡∏≤ low-molecular weight heparins thyroid hormone ‡∏Å‡∏î TSH ‡πÄ‡∏¢‡∏≠‡∏∞‡πÄ‡∏Å‡∏¥‡∏ô‡πÑ‡∏õ (&amp;lt;0.</description></item><item><title/><link>https://quartz.jzhao.xyz/notes/23-Steroid/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://quartz.jzhao.xyz/notes/23-Steroid/</guid><description> steroid ‡∏à‡∏∞‡πÑ‡∏°‡πà‡πÉ‡∏ä‡πâ‡πÄ‡∏î‡∏µ‡πà‡∏¢‡∏ß ‡πÜ ‡∏à‡∏∞‡∏ï‡πâ‡∏≠‡∏á‡πÉ‡∏ä‡πâ‡∏Ñ‡∏π‡πà‡∏Å‡∏±‡∏ö‡∏≠‡∏∞‡πÑ‡∏£‡∏™‡∏±‡∏Å‡∏≠‡∏¢‡πà‡∏≤‡∏á ‡∏ó‡∏µ‡πà‡πÄ‡∏õ‡πâ‡∏ô‡∏¢‡∏≤‡∏£‡∏±‡∏Å‡∏©‡∏≤‡∏Ç‡∏≠‡∏á‡πÇ‡∏£‡∏Ñ‡∏ô‡∏±‡πâ‡∏ô ‡πÜ steroid ‡πÉ‡∏ä‡πâ‡πÑ‡∏°‡πà‡πÄ‡∏Å‡∏¥‡∏ô 1 wks ‡πÑ‡∏°‡πà‡∏ï‡πâ‡∏≠‡∏á tape ‡πÑ‡∏°‡πà‡∏ï‡πâ‡∏≠‡∏á‡∏Å‡∏•‡∏±‡∏ß adrenal insuff ‡πÅ‡∏ï‡πà‡∏ñ‡πâ‡∏≤‡πÉ‡∏ä‡πâ‡∏û‡∏ß‡∏Å dexa ‡∏ó‡∏µ‡πà duration ‡∏ô‡∏≤‡∏ô‡∏≠‡∏≤‡∏à‡∏°‡∏µ‡πÇ‡∏≠‡∏Å‡∏≤‡∏™‡πÄ‡∏Å‡∏¥‡∏î adrenal insuff ‡∏™‡∏π‡∏á‡∏Å‡∏ß‡πà‡∏≤ steroid ‡∏™‡∏≥‡∏´‡∏£‡∏±‡∏ö autoimmune ‡∏à‡∏∞‡πÉ‡∏ä‡πâ high dose ‡∏õ‡∏£‡∏∞‡∏°‡∏≤‡∏ì 1-2 mg/kg/day ‡∏ñ‡πâ‡∏≤‡∏õ‡∏£‡∏±‡∏ö‡πÑ‡∏°‡πà‡πÄ‡∏´‡∏°‡∏≤‡∏∞‡∏à‡∏∞‡∏ï‡∏¥‡∏î‡∏¢‡∏≤ steroid ‡∏•‡∏î 50% ‡∏ó‡∏∏‡∏Å 1-2 weeks ‡∏î‡∏∏‡∏Å‡∏≤‡∏£‡∏Ñ‡∏∏‡∏°‡πÇ‡∏£‡∏Ñ ‡πÇ‡∏£‡∏Ñ autoimmune ‡∏°‡∏±‡∏Å‡∏à‡∏∞‡∏•‡∏î steroid ‡∏Å‡πà‡∏≠‡∏ô ‡πÉ‡∏´‡πâ‡∏ô‡πâ‡∏≠‡∏¢‡∏ó‡∏µ‡πà‡∏™‡∏∏‡∏î ‡∏´‡∏£‡∏∑‡∏≠‡∏´‡∏¢‡∏∏‡∏î‡πÑ‡∏î‡πâ‡∏è‡πá‡∏à‡∏∞‡∏î‡∏µ ‡∏ó‡∏ö‡∏ó‡∏ß‡∏ô ADR steroids</description></item><item><title/><link>https://quartz.jzhao.xyz/notes/25-SLE/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://quartz.jzhao.xyz/notes/25-SLE/</guid><description>Definition &amp;amp; Risk Factors ‡πÄ‡∏õ‡πá‡∏ô‡πÇ‡∏£‡∏Ñ autoimmune ‡∏ó‡∏±‡πâ‡∏á CMI, HMI ‡πÄ‡∏õ‡πá‡∏ô‡πÉ‡∏ô‡∏ú‡∏π‡πâ‡∏´‡∏ç‡∏¥‡∏á &amp;gt; ‡∏ú‡∏π‡πâ‡∏ä‡∏≤‡∏¢ ‡∏Æ‡∏≠‡∏£‡πå‡πÇ‡∏°‡∏ô ‡πÄ‡∏ä‡πà‡∏ô estrogen ‡πÄ‡∏õ‡πá‡∏ô‡πÉ‡∏ô‡∏ß‡∏±‡∏¢‡πÄ‡∏à‡∏£‡∏¥‡∏ç‡∏û‡∏±‡∏ô‡∏ò‡∏∏‡πå‡∏°‡∏≤‡∏Å‡∏Å‡∏ß‡πà‡∏≤ ‡∏û‡∏±‡∏ô‡∏ò‡∏∏‡∏Å‡∏£‡∏£‡∏°‡∏°‡∏µ‡∏™‡πà‡∏ß‡∏ô‡πÄ‡∏Å‡∏µ‡πà‡∏¢‡∏ß‡∏Ç‡πâ‡∏≠‡∏á ‡∏™‡∏¥‡πà‡∏á‡πÅ‡∏ß‡∏î‡∏•‡πâ‡∏≠‡∏° ‡∏™‡∏≤‡∏£‡∏ó‡∏µ‡πà‡πÑ‡∏î‡πâ‡∏£‡∏±‡∏ö‡∏Å‡πá‡∏°‡∏µ‡∏™‡πà‡∏ß‡∏ô‡πÄ‡∏Å‡∏µ‡πà‡∏¢‡∏ß‡∏Ç‡πâ‡∏≠‡∏á ‡∏Å‡∏≤‡∏£‡πÑ‡∏î‡πâ‡∏£‡∏±‡∏ö‡πÑ‡∏õ‡∏ô‡∏≤‡∏ô ‡πÜ ‡πÄ‡∏´‡∏°‡∏∑‡∏≠‡∏ô self-tolerance ‡∏Ç‡∏≠‡∏á innate immunity ‡∏•‡∏î‡∏•‡∏á ‡∏ó‡∏≥‡πÉ‡∏´‡πâ‡πÄ‡∏Å‡∏¥‡∏î auto-antibodies production ‡∏Å‡∏≤‡∏£‡∏ï‡∏¥‡∏î‡πÄ‡∏ä‡∏∑‡πâ‡∏≠ EBV UV Pathophysiology and Clinical Features ‡∏°‡∏µ‡∏Å‡∏≤‡∏£‡∏™‡∏£‡πâ‡∏≤‡∏á‡∏†‡∏π‡∏°‡∏¥‡∏Ñ‡∏∏‡πâ‡∏°‡∏Å‡∏±‡∏ô‡∏ï‡πà‡∏≠ nucleus ‡∏Ç‡∏≠‡∏á‡πÄ‡∏ã‡∏•‡∏•‡πå (autoantibody) ‡πÄ‡∏ä‡πà‡∏ô anti-dsDNA ‡πÅ‡∏•‡∏∞ anti-Sm immune complex ‡∏ó‡∏µ‡πà‡πÄ‡∏Å‡∏¥‡∏î‡πÑ‡∏õ‡∏ï‡∏Å‡∏ï‡∏∞‡∏Å‡∏≠‡∏ô‡∏ï‡∏≤‡∏°‡∏≠‡∏ß‡∏±‡∏¢‡∏ß‡∏∞‡∏ï‡πà‡∏≤‡∏á ‡πÜ ‡πÄ‡∏Å‡∏¥‡∏î‡∏≠‡∏≤‡∏Å‡∏≤‡∏£‡∏ï‡∏≤‡∏°‡∏≠‡∏ß‡∏±‡∏¢‡∏ß‡∏∞‡∏ô‡∏±‡πâ‡∏ô ‡πÜ ‡∏≠‡∏≤‡∏Å‡∏≤‡∏£‡∏ó‡∏µ‡πà‡∏û‡∏ö‡πÑ‡∏î‡πâ‡∏°‡∏≤‡∏Å‡∏ó‡∏µ‡πà‡∏™‡∏∏‡∏î‡∏à‡∏∞‡πÄ‡∏õ‡πá‡∏ô‡∏ó‡∏≤‡∏á‡∏Ç‡πâ‡∏≠‡πÅ‡∏•‡∏∞‡∏ú‡∏¥‡∏ß‡∏´‡∏ô‡∏±‡∏á (90%) ‡∏ã‡∏∂‡πà‡∏á‡∏´‡∏≤‡∏Å‡∏≠‡∏≤‡∏Å‡∏≤‡∏£‡∏°‡∏µ‡πÅ‡∏Ñ‡πà 2 ‡∏£‡∏∞‡∏ö‡∏ö‡∏ô‡∏µ‡πâ prognosis ‡∏°‡∏±‡∏Å‡∏à‡∏∞‡∏î‡∏µ ‡πÉ‡∏ô‡∏ó‡∏≤‡∏á‡∏ï‡∏£‡∏á‡∏Å‡∏±‡∏ô‡∏Ç‡πâ‡∏≤‡∏° ‡∏´‡∏≤‡∏Å‡∏°‡∏µ‡∏≠‡∏≤‡∏Å‡∏≤‡∏£‡∏ó‡∏µ‡πà‡∏£‡∏∞‡∏ö‡∏ö‡∏≠‡∏∑‡πà‡∏ô ‡πÜ ‡πÄ‡∏ä‡πà‡∏ô CNS ‡∏´‡∏£‡∏∑‡∏≠ renal ‡∏°‡∏±‡∏Å‡∏à‡∏∞ prognosis ‡∏´‡πà‡∏ß‡∏¢‡πÅ‡∏ï‡∏Å Skin ‡∏à‡∏∞‡∏°‡∏µ‡∏ú‡∏∑‡πà‡∏ô‡∏ó‡∏µ‡πà‡πÄ‡∏â‡∏û‡∏≤‡∏∞‡πÄ‡∏à‡∏≤‡∏∞‡∏à‡∏á‡∏Å‡∏±‡∏ö‡πÇ‡∏£‡∏Ñ acute LE malar rash or butterfly rash : ‡πÄ‡∏õ‡πâ‡∏ô‡∏ú‡∏∑‡πà‡∏ô‡∏ó‡∏µ‡πà‡πÑ‡∏°‡πà‡πÄ‡∏Å‡∏¥‡∏î‡πÉ‡∏ô‡∏ö‡∏£‡∏¥‡πÄ‡∏ß‡∏ì nasolabial folds bullous LE ‡πÄ‡∏õ‡πá‡∏ô‡∏ú‡∏∑‡πà‡∏ô‡∏ï‡∏∏‡πà‡∏°‡∏ô‡πâ‡∏≥ subacute LE psoriatic like, ‡∏ß‡∏á ‡πÜ ‡∏Ç‡∏≠‡∏ö‡πÅ‡∏î‡∏á ‡∏Å‡∏•‡∏≤‡∏á‡∏Ç‡∏≤‡∏ß chronic LE discoid rash ‡πÄ‡∏õ‡πá‡∏ô‡πÄ‡∏´‡∏°‡∏∑‡∏≠‡∏ô‡∏™‡πÄ‡∏Å‡πá‡∏î‡πÄ‡∏á‡∏¥‡∏ô‡πÄ‡∏•‡πá‡∏Å ‡πÜ ‡∏°‡∏µ‡∏™‡πÄ‡∏Å‡πá‡∏î ‡∏û‡∏ö hair scaring ‡∏à‡∏≤‡∏Å‡∏Å‡∏≤‡∏£‡∏ó‡∏µ‡πà‡∏ï‡πà‡∏≠‡∏°‡πÑ‡∏Ç‡∏°‡∏±‡∏ô‡πÅ‡∏•‡∏∞‡∏£‡∏π‡∏Ç‡∏∏‡∏°‡∏Ç‡∏ô‡∏ñ‡∏π‡∏Å‡∏ó‡∏≥‡∏ó‡∏•‡∏≤‡∏¢‡πÄ‡∏û‡∏£‡∏≤‡∏∞‡πÄ‡∏°‡πá‡∏î‡πÄ‡∏•‡∏∑‡∏≠‡∏î‡∏Ç‡∏≤‡∏ß Joint arthritis ‡∏°‡∏≤‡∏Å‡∏Å‡∏ß‡πà‡∏≤ 2 ‡∏Ç‡πâ‡∏≠ ‡∏Ñ‡∏•‡πâ‡∏≤‡∏¢ RA +- ‡∏õ‡∏ß‡∏î ‡∏Å‡∏≤‡∏£‡∏î‡∏≥‡πÄ‡∏ô‡∏¥‡∏ô‡πÇ‡∏£‡∏Ñ‡πÑ‡∏°‡πà‡πÄ‡∏£‡∏∑‡πâ‡∏≠‡∏£‡∏±‡∏á ‡∏ú‡∏• film ‡∏à‡∏∞‡πÑ‡∏°‡πà‡πÄ‡∏à‡∏≠ erosion!</description></item><item><title/><link>https://quartz.jzhao.xyz/notes/3-Drug-Induced-Pulmonary-Disease/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://quartz.jzhao.xyz/notes/3-Drug-Induced-Pulmonary-Disease/</guid><description>ps. incidence unknown ‡πÄ‡∏û‡∏£‡∏≤‡∏∞‡∏á‡∏≤‡∏ô‡∏ß‡∏¥‡∏à‡∏±‡∏¢‡∏°‡∏µ‡∏ô‡πâ‡∏≠‡∏¢ ‡∏Å‡∏≤‡∏£‡πÄ‡∏Å‡πá‡∏ö‡∏Ç‡πâ‡∏≠‡∏°‡∏π‡∏•‡∏°‡∏µ‡∏ô‡πâ‡∏≠‡∏¢
Drug Induced Apnea Definitions: ‡∏≠‡∏∏‡∏î‡∏Å‡∏±‡πâ‡∏ô‡∏ó‡∏≤‡∏á‡πÄ‡∏î‡∏¥‡∏ô‡∏´‡∏≤‡∏¢‡πÉ‡∏à‡∏™‡∏°‡∏ö‡∏π‡∏£‡∏ì‡πå ‡∏´‡∏£‡∏∑‡∏≠ ‡∏≠‡∏∏‡∏î‡∏Å‡∏±‡πâ‡∏ô‡∏ö‡∏≤‡∏á‡∏™‡πà‡∏ß‡∏ô‡πÅ‡∏ï‡πà‡∏°‡∏µ‡∏õ‡∏±‡∏à‡∏à‡∏±‡∏¢‡πÄ‡∏™‡∏£‡∏¥‡∏° ‡∏Å‡∏•‡πÑ‡∏Å: CNS Depression, Respiratory muscle dysfunction, Myopathy Drug Causes: BZDs + Phenobarbital to stop status epilepticus (‡πÑ‡∏°‡πà‡∏™‡∏±‡∏°‡∏û‡∏±‡∏ô‡∏ò‡πå‡∏Å‡∏±‡∏ö rate ‡∏¢‡∏≤) ‡∏≠‡∏≤‡∏à‡πÉ‡∏™‡πà mechanical ventilation ‡∏Å‡πà‡∏≠‡∏ô‡πÉ‡∏´‡πâ‡∏¢‡∏≤ BZDs ‡πÄ‡∏Å‡∏¥‡∏î‡∏ö‡πà‡∏≠‡∏¢‡∏°‡∏≤‡∏Å ‡πÄ‡∏Å‡∏µ‡πà‡∏¢‡∏ß‡∏Å‡∏±‡∏ö t1/2 ‡∏Ç‡∏≠‡∏á‡∏¢‡∏≤ ‡πÄ‡∏ä‡πà‡∏ô long-acting ‡∏¢‡∏±‡∏á‡∏§‡∏ó‡∏ò‡∏¥‡πå‡πÑ‡∏°‡πà‡∏´‡∏°‡∏î‡πÅ‡∏•‡πâ‡∏ß‡∏°‡∏≤‡πÉ‡∏ä‡πâ short-acting ‡∏¢‡∏≤‡∏ó‡∏∏‡∏Å‡∏Å‡∏•‡∏∏‡πà‡∏°‡πÄ‡∏™‡∏µ‡πà‡∏¢‡∏á‡πÄ‡∏ó‡πà‡∏≤‡∏Å‡∏±‡∏ô ‡πÑ‡∏°‡πà‡∏Ñ‡∏ß‡∏£‡πÉ‡∏ä‡πâ‡∏£‡πà‡∏ß‡∏° opioid ‡∏´‡∏£‡∏∑‡∏≠ CYP3A4 inhibitors ‡πÑ‡∏°‡πà‡∏Ñ‡∏ß‡∏£‡πÉ‡∏ä‡πâ‡πÉ‡∏ô‡∏ú‡∏π‡πâ‡∏™‡∏π‡∏á‡∏≠‡∏≤‡∏¢‡∏∏ Neuromuscular blocking agents ‡∏Å‡∏≤‡∏£‡πÉ‡∏ä‡πâ‡∏£‡∏∞‡∏¢‡∏∞‡πÄ‡∏ß‡∏•‡∏≤‡∏ô‡∏≤‡∏ô ‡∏£‡∏∞‡∏ß‡∏±‡∏á‡πÉ‡∏ô‡∏Ñ‡∏ô‡∏°‡∏µ‡∏õ‡∏±‡∏ç‡∏´‡∏≤‡∏ï‡∏±‡∏ö‡πÑ‡∏ï ‡∏û‡∏ö‡πÄ‡∏à‡∏≠‡πÉ‡∏ô‡∏Ñ‡∏ô‡πÉ‡∏ä‡πâ pancuronium ‡πÅ‡∏•‡∏∞ vecuronium Steroids ‡∏Ç‡∏∂‡πâ‡∏ô‡∏Å‡∏±‡∏ö‡πÇ‡∏î‡∏™ #recall1 fluorinated steroid ‡πÄ‡∏ä‡πà‡∏ô triam, dexa ‡∏°‡∏µ‡πÇ‡∏≠‡∏Å‡∏≤‡∏™‡∏Å‡∏¥‡∏î myopathy ‡∏™‡∏π‡∏á‡∏Å‡∏ß‡πà‡∏≤‡πÄ‡∏û‡∏£‡∏≤‡∏∞ lipophilicity ‡∏™‡∏π‡∏á #recall1 ‡πÉ‡∏ô‡∏Å‡∏≤‡∏£‡∏®‡∏∂‡∏Å‡∏©‡∏≤‡∏™‡∏±‡∏ï‡∏ß‡πå‡∏û‡∏ö‡∏ß‡πà‡∏≤ ‡∏Ç‡∏ô‡∏≤‡∏î‡∏°‡∏≤‡∏Å‡∏Å‡∏ß‡πà‡∏≤‡∏´‡∏£‡∏∑‡∏≠‡πÄ‡∏ó‡πà‡∏≤‡∏Å‡∏±‡∏ö 2mg/kg prednisolone ‡∏ó‡∏≥‡πÉ‡∏´‡πâ atrohpy Drug Induced Asthma/Bronchospasm ‡∏´‡∏•‡∏≤‡∏¢‡∏Å‡∏•‡πÑ‡∏Å ‡∏≠‡∏≤‡∏à‡∏°‡∏µ‡∏à‡∏≤‡∏Å‡∏Å‡∏≤‡∏£‡πÅ‡∏û‡πâ‡∏´‡∏£‡∏∑‡∏≠‡πÑ‡∏°‡πà‡πÅ‡∏û‡πâ‡∏Å‡πá‡πÑ‡∏î‡πâ (anaphylaxis or anaphylactoid) ‡∏û‡∏ö‡∏ö‡πà‡∏≠‡∏¢‡πÉ‡∏ô‡∏Ñ‡∏ô‡∏ó‡∏µ‡πà‡∏°‡∏µ‡∏õ‡∏±‡∏à‡∏à‡∏±‡∏¢‡πÄ‡∏™‡∏µ‡πà‡∏¢‡∏á ‡πÅ‡∏û‡πâ‡∏¢‡∏≤ ‡∏´‡∏£‡∏∑‡∏≠ asthma ‡πÄ‡∏î‡∏¥‡∏°‡∏≠‡∏¢‡∏π‡πà‡πÅ‡∏•‡πâ‡∏ß ‡∏¢‡∏≤‡∏ó‡∏µ‡πà‡∏û‡∏ö‡∏ö‡πà‡∏≠‡∏¢ NSAIDs (Cox1) / Aspirin !</description></item><item><title/><link>https://quartz.jzhao.xyz/notes/4-Respiratory-Failure/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://quartz.jzhao.xyz/notes/4-Respiratory-Failure/</guid><description>Basics to Respiratory Failure Respiratory Disease Obstructive lung disease (small airway obstruction), asthma, chronic bronchitis Restrictive lung disease (reduced lung volume), pulmonary fibrosis, disease of the chest wall or pleura Abnormalities of the vasculature, pulmonary embolism and pulmonary hypertension Others: malignancy and pneumonia Respiratory Distress patient&amp;rsquo;s subjective sensation of dyspnea + signs indicated difficulty breathing Dyspnea feeling of difficult, labored, uncomfortable breathing ‡∏´‡∏£‡∏∑‡∏≠‡∏°‡∏µ PE ‡πÄ‡∏ä‡πà‡∏ô tachypnea and tachycardia, use of accessory respiratory muscle Respiratory Failure is defined as inadequate gas exchange Classification Type 1 : hypoxia (PaO2 &amp;lt; 60 mmHg) + PaCO2 Normal Type 2 : hypoxia (PaO2 &amp;lt; 60 mmHg) + hypercapnia (PaCO2 &amp;gt; 45 mmHg) Typical approach to respiratory disease: PMH (optional) ‡∏ñ‡πâ‡∏≤‡∏°‡∏µ‡∏Å‡πá‡∏à‡∏∞‡∏ä‡πà‡∏ß‡∏¢ R/O ‡πÑ‡∏î‡πâ‡∏ß‡πà‡∏≤‡∏°‡∏≤‡∏à‡∏≤‡∏Å‡∏≠‡∏∞‡πÑ‡∏£ ‡πÄ‡∏ä‡πà‡∏ô HF, ‡∏°‡∏∞‡πÄ‡∏£‡πá‡∏á‡∏õ‡∏≠‡∏î PE LAB (optional) Physical Examination Summary !</description></item><item><title/><link>https://quartz.jzhao.xyz/notes/5-Acute-Asthma-COPD-Exacerbation/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://quartz.jzhao.xyz/notes/5-Acute-Asthma-COPD-Exacerbation/</guid><description>Definitions Asthma: progressive increase in asthma symptoms COPD: dyspnea and/or cough and sputum that worsen over &amp;lt; 14 days ‡∏ñ‡πâ‡∏≤‡∏°‡∏µ fever ‡∏≠‡∏≤‡∏à‡πÄ‡∏õ‡πá‡∏ô complication ‡∏≠‡∏¢‡πà‡∏≤‡∏á‡∏≠‡∏∑‡πà‡∏ô ‡∏≠‡∏≤‡∏à‡∏à‡πÄ‡∏õ‡πá‡∏ô CAP associated COPD exacerbation Criteria for acute exacerbation Asthma: typical symptoms / ‡πÑ‡∏°‡πà‡πÑ‡∏î‡πâ‡πÄ‡∏ô‡πâ‡∏ô sputum ‡πÅ‡∏ï‡πà‡∏à‡∏∞ progressive COPD: Worsening symptoms of dyspnea or increase in sputum volume or increase in sputum purulence #recall1 Pathophysiology !</description></item><item><title/><link>https://quartz.jzhao.xyz/notes/7-Glaucoma-%E0%B8%95%E0%B9%89%E0%B8%AD%E0%B8%AB%E0%B8%B4%E0%B8%99/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://quartz.jzhao.xyz/notes/7-Glaucoma-%E0%B8%95%E0%B9%89%E0%B8%AD%E0%B8%AB%E0%B8%B4%E0%B8%99/</guid><description>![[Pasted image 20230202192433.png|475]]
IOP ‡∏ó‡∏µ‡πà‡∏™‡∏π‡∏á‡∏ó‡∏≥‡πÉ‡∏´‡πâ‡πÄ‡∏Å‡∏¥‡∏î optic neuropathy (‡∏ó‡∏≥‡∏•‡∏≤‡∏¢‡∏£‡∏∞‡∏ö‡∏ö‡∏õ‡∏£‡∏∞‡∏™‡∏≤‡∏ó‡∏ï‡∏≤) ‡∏ó‡∏≥‡πÉ‡∏´‡πâ Cup to Disk Ratio &amp;gt; 0.5 (‡∏õ‡∏Å‡∏ï‡∏¥ 0.33-0.5) Splinter hemorrhage ‡πÄ‡∏•‡∏∑‡∏≠‡∏î‡∏ó‡∏µ‡πà‡∏≠‡∏≠‡∏Å‡∏°‡∏µ oxidative stress ‡πÄ‡∏õ‡πâ‡∏ô cell toxicity Nerve fiber defects Blind spot enlargement Aqueous humor ‡∏™‡∏£‡πâ‡∏≤‡∏á‡∏à‡∏≤‡∏Å ciliary body ‡∏ó‡∏≥‡∏´‡∏ô‡πâ‡∏≤‡∏ó‡∏µ‡πà‡∏£‡∏±‡∏Å‡∏©‡∏≤ IOP ‡πÉ‡∏´‡πâ‡∏≠‡∏¢‡∏π‡πà‡∏ä‡πà‡∏ß‡∏á‡∏õ‡∏Å‡∏ï‡∏¥ Aqueous humor ‡∏£‡∏∞‡∏ö‡∏≤‡∏¢‡∏≠‡∏≠‡∏Å‡∏ó‡∏≤‡∏á Trabecular meshwork (85-95%) ‡πÅ‡∏•‡∏∞ Uveoscleral route (5-15%) #recall1 Tonometry ‡∏Ñ‡∏∑‡∏≠‡∏Å‡∏≤‡∏£‡∏ß‡∏±‡∏î‡πÅ‡∏£‡∏á‡∏î‡∏±‡∏ô‡πÉ‡∏ô‡∏ï‡∏≤ ‡πÅ‡∏ï‡πà‡∏õ‡∏±‡∏à‡∏à‡∏∏‡∏ö‡∏±‡∏ô‡∏ô‡∏¥‡∏¢‡∏° Fundoscopy ‡∏°‡∏≤‡∏Å‡∏Å‡∏ß‡πà‡∏≤ IOP ‡πÄ‡∏õ‡πá‡∏ô‡πÅ‡∏Ñ‡πà risk ‡∏´‡∏ô‡∏∂‡πà‡∏á‡πÉ‡∏ô‡∏Å‡∏≤‡∏£‡πÄ‡∏Å‡∏¥‡∏î Glaucoma ‡πÑ‡∏°‡πà‡πÑ‡∏î‡πâ‡∏ö‡πà‡∏á‡∏ö‡∏≠‡∏Å‡∏ß‡πà‡∏≤‡∏à‡∏∞‡πÄ‡∏Å‡∏¥‡∏î‡πÄ‡∏™‡∏°‡∏≠‡πÑ‡∏õ ‡∏Ñ‡∏ô‡∏ö‡∏≤‡∏á‡∏Ñ‡∏ô IOP ‡∏ô‡πâ‡∏≠‡∏¢ (ex.</description></item><item><title/><link>https://quartz.jzhao.xyz/notes/8-AMD/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://quartz.jzhao.xyz/notes/8-AMD/</guid><description>AMD = Age-Related Macular Degeneration : AMD AMD ‡πÑ‡∏°‡πà‡πÉ‡∏ä‡πà CPU ‡πÅ‡∏ï‡πà‡∏Ñ‡∏∑‡∏≠‡πÇ‡∏£‡∏Ñ ![[Pasted image 20230201155250.png|225]] AMD = neurodegenerative disease retinal pigment epithelial ‡∏ö‡∏£‡∏¥‡πÄ‡∏ß‡∏ì macula ‡∏ñ‡∏π‡∏Å‡∏ó‡∏≥‡∏•‡∏≤‡∏¢‡πÄ‡∏Å‡∏¥‡∏î loss of central vision RPE ‡∏°‡∏µ photoreceptor ‡πÄ‡∏¢‡∏≠‡∏∞ Note: glaucoma ‡∏à‡∏∞‡πÄ‡∏õ‡πá‡∏ô‡∏ó‡∏µ‡πà optic nerve!</description></item><item><title/><link>https://quartz.jzhao.xyz/notes/9-Drug-Induced-Eye-Disorder/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://quartz.jzhao.xyz/notes/9-Drug-Induced-Eye-Disorder/</guid><description>Management dose, duration, t1/2 physicochemical properties individual blood-retina barrier/ blood-aqueous barrier/ physio/ ‡∏¢‡∏≤‡∏≠‡∏∑‡πà‡∏ô ‡πÜ monitoring : monitor what drug? what to monitor?</description></item><item><title/><link>https://quartz.jzhao.xyz/notes/Exam-1-Addition-Notes/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://quartz.jzhao.xyz/notes/Exam-1-Addition-Notes/</guid><description>[[Inhaler Products]] Asthma Normal Diagnosis ‡∏î‡∏π‡∏à‡∏≤‡∏Å FEV1/FVC &amp;lt;0.75-0.8 (adult) ‡πÅ‡∏•‡∏∞ post broncho FEV1 &amp;gt; 12% ‡∏´‡∏£‡∏∑‡∏≠ PEF &amp;gt; 10% ‡∏Å‡∏≤‡∏£‡∏£‡∏±‡∏Å‡∏©‡∏≤ step1-2 ICS ‡πÑ‡∏°‡πà‡πÑ‡∏î‡πâ‡∏Å‡πá‡πÉ‡∏ä‡πâ montelukast add HDM ‡∏ñ‡πâ‡∏≤‡πÅ‡∏û‡πâ ‡∏£‡∏∞‡∏ß‡∏±‡∏á anaphylaxis step3 -&amp;gt; ‡∏Å‡∏£‡∏ì‡∏µ‡∏ó‡∏µ‡πà &amp;gt;5 days ‡∏≠‡∏≤‡∏Å‡∏≤‡∏£ ‡πÉ‡∏ä‡πâ symbicort ‡πÅ‡∏ö‡∏ö od ‡πÑ‡∏°‡πà‡πÉ‡∏ä‡πà as-needed!</description></item><item><title>Callouts</title><link>https://quartz.jzhao.xyz/notes/callouts/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://quartz.jzhao.xyz/notes/callouts/</guid><description>Callout support Quartz supports the same Admonition-callout syntax as Obsidian.
This includes
12 Distinct callout types (each with several aliases) Collapsable callouts See documentation on supported types and syntax here.</description></item><item><title>CJK + Latex Support (ÊµãËØï)</title><link>https://quartz.jzhao.xyz/notes/CJK-+-Latex-Support-%E6%B5%8B%E8%AF%95/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://quartz.jzhao.xyz/notes/CJK-+-Latex-Support-%E6%B5%8B%E8%AF%95/</guid><description>Chinese, Japanese, Korean Support Âá†‰πéÂú®Êàë‰ª¨ÊÑèËØÜÂà∞‰πãÂâçÔºåÊàë‰ª¨Â∑≤ÁªèÁ¶ªÂºÄ‰∫ÜÂú∞Èù¢„ÄÇ
Ïö∞Î¶¨Í∞Ä Í∑∏Í≤ÉÏùÑ ÏïåÍ∏∞ÎèÑ Ï†ÑÏóê Ïö∞Î¶¨Îäî ÎïÖÏùÑ Îñ†ÎÇ¨ÏäµÎãàÎã§.
ÁßÅ„Åü„Å°„Åå„Åù„Çå„ÇíÁü•„Çã„Åª„ÅºÂâç„Å´„ÄÅÁßÅ„Åü„Å°„ÅØÂú∞Èù¢„ÇíÈõ¢„Çå„Å¶„ÅÑ„Åæ„Åó„Åü„ÄÇ
Latex Block math works with two dollar signs $$.</description></item><item><title>Configuration</title><link>https://quartz.jzhao.xyz/notes/config/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://quartz.jzhao.xyz/notes/config/</guid><description>Configuration Quartz is designed to be extremely configurable. You can find the bulk of the configuration scattered throughout the repository depending on how in-depth you&amp;rsquo;d like to get.</description></item><item><title>Custom Domain</title><link>https://quartz.jzhao.xyz/notes/custom-Domain/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://quartz.jzhao.xyz/notes/custom-Domain/</guid><description>Registrar This step is only applicable if you are using a custom domain! If you are using a &amp;lt;YOUR-USERNAME&amp;gt;.github.io domain, you can skip this step.</description></item><item><title>Hosting with Docker</title><link>https://quartz.jzhao.xyz/notes/docker/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://quartz.jzhao.xyz/notes/docker/</guid><description>If you want to host Quartz on a machine without using a webpage hosting service, it may be easier to install Docker Compose and follow the instructions below than to install Quartz&amp;rsquo;s dependencies manually.</description></item><item><title>Ignoring Notes</title><link>https://quartz.jzhao.xyz/notes/ignore-notes/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://quartz.jzhao.xyz/notes/ignore-notes/</guid><description>Quartz Ignore Edit ignoreFiles in config.toml to include paths you&amp;rsquo;d like to exclude from being rendered.
1 2 3 4 5 6 .</description></item><item><title>Quartz Philosophy</title><link>https://quartz.jzhao.xyz/notes/philosophy/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://quartz.jzhao.xyz/notes/philosophy/</guid><description>‚Äú[One] who works with the door open gets all kinds of interruptions, but [they] also occasionally gets clues as to what the world is and what might be important.</description></item><item><title>Search</title><link>https://quartz.jzhao.xyz/notes/search/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://quartz.jzhao.xyz/notes/search/</guid><description>Quartz supports two modes of searching through content.
Full-text Full-text search is the default in Quartz. It produces results that exactly match the search query.</description></item><item><title>Showcase</title><link>https://quartz.jzhao.xyz/notes/showcase/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://quartz.jzhao.xyz/notes/showcase/</guid><description>Want to see what Quartz can do? Here are some cool community gardens :)
Quartz Documentation (this site!) Jacky Zhao&amp;rsquo;s Garden Scaling Synthesis - A hypertext research notebook AWAGMI Intern Notes Shihyu&amp;rsquo;s PKM SlRvb&amp;rsquo;s Site Course notes for Information Technology Advanced Theory Brandon Boswell&amp;rsquo;s Garden Siyang&amp;rsquo;s Courtyard Data Dictionary üß† sspaeti.</description></item><item><title>Troubleshooting and FAQ</title><link>https://quartz.jzhao.xyz/notes/troubleshooting/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://quartz.jzhao.xyz/notes/troubleshooting/</guid><description>Still having trouble? Here are a list of common questions and problems people encounter when installing Quartz.
While you&amp;rsquo;re here, join our Discord :)</description></item><item><title>Updating</title><link>https://quartz.jzhao.xyz/notes/updating/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://quartz.jzhao.xyz/notes/updating/</guid><description>Haven&amp;rsquo;t updated Quartz in a while and want all the cool new optimizations? On Unix/Mac systems you can run the following command for a one-line update!</description></item></channel></rss>